Dabrafenib
Product Specifications
CAS Number
1195765-45-7
Target
Raf
Related Pathways
MAPK
Purity
>99.99%
Bioactivity
Dabrafenib (GSK2118436A) is a Raf inhibitor that inhibits C-Raf and B-RafV600E (IC50=5/0.6 nM) and is ATP-competitive. Dabrafenib exhibits antitumor activity for the treatment of B-RafV600E-mutated melanoma.
Smiles
CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F
Molecular Formula
C23H20F3N5O2S2
Molecular Weight
519.56
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG-P091608-01 10 mg
N1- (2- (Piperazin-1-Yl) Ethyl) Ethane-1,2-Diamine
Sign In for Pricing
View Details RG-P091608-02 25 mg
N1- (2- (Piperazin-1-Yl) Ethyl) Ethane-1,2-Diamine
Sign In for Pricing
View Details RG-P091608-03 50 mg
N1- (2- (Piperazin-1-Yl) Ethyl) Ethane-1,2-Diamine
Sign In for Pricing
View Details RG-P091608-04 100 mg
N1- (2- (Piperazin-1-Yl) Ethyl) Ethane-1,2-Diamine
Sign In for Pricing
View Details 302674-HRP 100 µL
PRSS21 (Testisin, 3421-, Eosinophil Serine Protease 1, ESP-1, Serine Protease 21, PRSS21, ESP1, TEST1) (HRP) discontinued
Sign In for Pricing
View Details 
B14112-01 25 g
N, N-bis (2-Hydroxyethyl) -2-aminoethane sulfonic acid
Sign In for Pricing
View Details